Related Experiment Video

Updated: Aug 11, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

882

The Role of Signaling Pathways in Pancreatic Cancer Targeted Therapy

Fangfang Zhuo1,2, Shuang Luo1,2, Wei He1,2

  • 1National Joint Local Engineering Laboratory for Cell Engineering and Biomedicine Technique, Guizhou Province Key Laboratory of Regenerative Medicine, Key Laboratory of Adult Stem Cell Translational Research (Chinese Academy of Medical Sciences).

American Journal of Clinical Oncology
|February 3, 2023
PubMed

Insights

Signaling pathways are crucial in pancreatic cancer (PC) development and treatment. Understanding these pathways, like PI3K/AKT and Wnt, can help overcome chemotherapy resistance and improve patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Signaling pathways are integral to pancreatic cancer (PC) occurrence, progression, and therapeutic response.
  • Key pathways implicated include phosphoinositide 3-kinase (PI3K)/AKT, nuclear factor-κB, Ras, interleukin (IL)-17B/IL-17RB, Wnt, and hepatocyte growth factor/c-MET.
  • These pathways influence critical processes such as proliferation, metastasis, invasion, apoptosis inhibition, angiogenesis, and drug resistance in PC.

Purpose of the Study:

  • To review the roles of various signaling pathways in the development of pancreatic cancer.
  • To discuss the current research on targeting these signaling pathways for effective PC treatment.
  • To highlight the impact of signaling pathway interactions on PC biology and therapeutic resistance.

Main Methods:

  • Literature review of studies on signaling pathways in pancreatic cancer.
  • Analysis of pathway involvement in PC pathogenesis and progression.
  • Examination of current therapeutic strategies targeting signaling pathways in PC.

Main Results:

  • Multiple signaling pathways, including PI3K/AKT, NF-κB, and Wnt, are significantly involved in PC development and progression.
  • Pathway interactions, such as neurotensin/NTSR1 activating MAPK and NF-κB, influence PC stem cell pathways.
  • Abnormal IL-17B/IL-17RB signaling is linked to chemotherapy resistance, a major challenge in PC treatment.

Conclusions:

  • Signaling pathways are critical determinants of pancreatic cancer's biological behavior and response to therapy.
  • Targeting specific signaling pathways holds promise for overcoming drug resistance and improving PC treatment efficacy.
  • Further research into pathway crosstalk and targeted therapies is essential for advancing pancreatic cancer care.

More Related Videos

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

2.9K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.7K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.6K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K